Prevalence and Associations of the Use of Proton-Pump Inhibitors in Nursing Homes: A Cross-Sectional Study

Journal of the American Medical Directors Association

Volumn 14, Issue 4, 2013, Pages 265-269

  De Souto Barreto, Philipe ^a,b   Lapeyre Mestre, Maryse ^a,c   Mathieu, Céline ^d   Piau, Christine ^e   Bouget, Catherine ^e   Cayla, Françoise ^d   Vellas, Bruno ^a,c   Rolland, Yves ^a,c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Faculté de Médecine Centre Hospitalo universitaire   (France)

^d Observatoire Régional de La Santé de Midi Pyrénées ORSMIP   (France)

^e Agence régionale de l'hospitalisation de Midi Pyrénées   (France)

Author keywords

Acid suppressive drugs; Elderly; Institutional setting; Older adults

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADL DISABILITY; AGED; ARTICLE; BEHAVIOR DISORDER; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; DEMENTIA; DEPRESSION; DRUG USE; FEMALE; FRANCE; GENERAL CONDITION; HEALTH HAZARD; HEART INFARCTION; HEMIPLEGIA; HOSPITALIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NURSING HOME; NURSING HOME PATIENT; NURSING HOME PERSONNEL; PAIN; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; POLYPHARMACY; PRESCRIPTION; PREVALENCE; VULNERABLE POPULATION;

EID: 84878016673     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2012.10.018     Document Type: Article

References (31)

1. Haute Autorité de Santé. [Proton-pump inhibitors drugs in adults: Re-evaluation]. 2009. Document in French: Accessed August 20, 2012. http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-04/argumentaire_ipp_2009-04-27_14-15-18_458.pdf.
2. Choudhry M.N., Soran H., Ziglam H.M. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease. QJM 2008, 101:445-448.
3. Zink D.A., Pohlman M., Barnes M., Cannon M.E. Long-term use of acid suppression started inappropriately during hospitalization. Aliment Pharmacol Ther 2005, 21:1203-1209.
4. Sheen E., Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci 2011, 56:931-950.
5. Sommet A., Durrieu G., Lapeyre-Mestre M., Montastruc J.-L. A comparative study of adverse drug reactions during 2 heat waves that occurred in France in 2003 and 2006. Pharmacoepidemiol Drug Saf 2012, 21:285-288.
6. Michenot F., Sommet A., Bagheri H., et al. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database. Pharmacoepidemiol Drug Saf 2006, 15:735-740.
7. Valuck R.J., Ruscin J.M. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol 2004, 57:422-428.
8. Dial S., Kezouh A., Dascal A., et al. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ 2008, 179:767-772.
9. Humphries T.J., Merritt G.J. Review article: Drug interactions with agents used to treat acid-related diseases. Aliment Pharmacol Ther 1999, 13:18-26.
10. Abrahamsen B., Eiken P., Eastell R. Proton pump inhibitor use and the antifracture efficacy of alendronate. Arch Intern Med 2011, 171:998-1004.
11. Herzig S.J., Howell M.D., Ngo L.H., Marcantonio E.R. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009, 301:2120-2128.
12. van der Maarel-Wierink C.D., Vanobbergen J.N.O., Bronkhorst E.M., et al. Risk factors for aspiration pneumonia in frail older people: A systematic literature review. J Am Med Dir Assoc 2011, 12:344-354.
13. Teramura-Grönblad M., Bell J.S., Pöysti M.M., et al. Risk of death associated with use of PPIs in 3 cohorts of institutionalized older people in Finland. J Am Med Dir Assoc 2012, 13:488.e9-488.e13.
14. Teramura-Grönblad M., Hosia-Randell H., Muurinen S., Pitkala K. Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents. Scand J Prim Health Care 2010, 28:154-159.
15. Hutchinson C., Geissler C.A., Powell J.J., Bomford A. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut 2007, 56:1291-1295.
16. Cundy T., Mackay J. Proton pump inhibitors and severe hypomagnesaemia. Curr Opin Gastroenterol 2011, 27:180-185.
17. Henry E.B., Carswell A., Wirz A., et al. Proton pump inhibitors reduce the bioavailability of dietary vitamin C. Aliment Pharmacol Ther 2005, 22:539-545.
18. McColl K.E.L. Effect of proton pump inhibitors on vitamins and iron. Am J Gastroenterol 2009, 104:S5-S9.
19. van Leen M.W.F., van der Eijk I., Schols J.M.G.A. Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes. Age Ageing 2007, 36:414-418.
20. Chen L.-K., Peng L.-N., Lin M.-H., et al. Predicting mortality of older residents in long-term care facilities: Comorbidity or care problems?. J Am Med Dir Assoc 2010, 11:567-571.
21. Bronskill S.E., Gill S.S., Paterson J.M., et al. Exploring variation in rates of polypharmacy across long term care homes. J Am Med Dir Assoc 2012, 13:309.e15-309.e21.
22. Rolland Y., Abellan van Kan G., Hermabessiere S., et al. Descriptive study of nursing home residents from the REHPA network. J Nutr Health Aging 2009, 13:679-683.
23. Barreto P.S., Lapeyre-Mestre M., Mathieu C., et al. A multicentric individually-tailored controlled trial of education and professional support to nursing home staff: Research protocol and baseline data of the IQUARE study. J Nutr Health Aging 2013, 17:173-178.
24. Benjamini Y., Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995, 57:289-300.
25. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
26. Hosmer D.W., Hosmer T., Le Cessie S., et al. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997, 16:965-980.
27. Sheu J.-J., Kang J.-H., Lou H.-Y., Lin H.-C. Reflux esophagitis and the risk of stroke in young adults: A 1-year population-based follow-up study. Stroke 2010, 41:2033-2037.
28. Pouwels S., Lalmohamed A., Souverein P., et al. Use of proton pump inhibitors and risk of hip/femur fracture: A population-based case-control study. Osteoporos Int 2011, 22:903-910.
29. García-Gollarte F., Baleriola-Júlvez J., Ferrero-López I., Cruz-Jentoft A.J. Inappropriate drug prescription at nursing home admission. J Am Med Dir Assoc 2012, 13:83.e9-83.e15.
30. Dent J., El-Serag H.B., Wallander M.-A., Johansson S. Epidemiology of gastro-oesophageal reflux disease: A systematic review. Gut 2005, 54:710-717.
31. Kojima G., Bell C., Tamura B., et al. Reducing cost by reducing polypharmacy: The Polypharmacy Outcomes Project. J Am Med Dir Assoc 2012, 13:818.e11-818.e15.